A critical role of non-classical MHC in tumor immune evasion in the amphibian Xenopus model.

Non-classical class Ib (class Ib) genes are found in all jawed vertebrates, including the amphibian Xenopus, which possesses at least 20 distinct Xenopus non-classical class Ib genes (XNCs). As an immune evasion strategy, tumors often downregulate surface expression of classical major histocompatibility complex class Ia molecules. In contrast, cancers commonly express class Ib molecules, presenting an alternative for tumor immune recognition. We characterized a novel XNC, XNC10, functionally similar to CD1d from a class Ia-deficient thymic lymphoid tumor (15/0), which grows aggressively in Xenopus LG-15 cloned animals. To investigate the roles of XNC10 in antitumor immunity, we generated stable 15/0-transfectants with silenced XNC10 mRNA and protein expression. Notably, XNC10 silencing resulted in acute tumor rejection by naturally class Ia-deficient syngeneic tadpoles, with greater potency of rejection in tumors with more efficient XNC10 knockdown. In vivo killing assays shows that the rejection of XNC10-deficient tumors is due to a cell-mediated cytotoxic immune response elicited by the tadpole host. Importantly, priming enhances XNC10-deficient tumor rejection. Flow cytometry reveals that XNC10-deficient tumor rejection is associated with an accumulation of XNC10-restricted invariant T cells and conventional CD8 T cells as well as other leukocytes. Similarly, semisolid tumor grafts in tadpoles also exhibit leukocytes infiltration. These findings suggest that XNC10 allows the 15/0-tumor to escape immune recognition and class Ia-independent cytotoxicity, thus emphasizing the critical roles of class Ibs in tumor immunity.

[1]  Jason R. Myers,et al.  Nonclassical MHC class I-dependent invariant T cells are evolutionarily conserved and prominent from early development in amphibians , 2013, Proceedings of the National Academy of Sciences.

[2]  S. Demaria,et al.  Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors , 2012, Clinical & developmental immunology.

[3]  M. Weller,et al.  HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells , 2012, Journal of Neuroimmunology.

[4]  B. Seliger,et al.  The role of classical and non-classical HLA class I antigens in human tumors. , 2012, Seminars in cancer biology.

[5]  Wenfu Zhou,et al.  HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer. , 2011, Lung cancer.

[6]  P. Stein,et al.  CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis , 2011, PloS one.

[7]  Y. Ohta,et al.  Remarkable Conservation of Distinct Nonclassical MHC Class I Lineages in Divergent Amphibian Species , 2011, The Journal of Immunology.

[8]  H. Putter,et al.  HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients , 2010, The Journal of Immunology.

[9]  J. Robert,et al.  Comparative in vivo study of gp96 adjuvanticity in the frog Xenopus laevis. , 2010, Journal of visualized experiments : JoVE.

[10]  J. Robert,et al.  Innate Immune Responses and Permissiveness to Ranavirus Infection of Peritoneal Leukocytes in the Frog Xenopus laevis , 2010, Journal of Virology.

[11]  Y. Ohta,et al.  Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors. , 2009, Molecular immunology.

[12]  E. Donadi,et al.  Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[13]  J. Robert,et al.  Involvement of nonclassical MHC class Ib molecules in heat shock protein‐mediated anti‐tumor responses , 2007, European journal of immunology.

[14]  K. Hatake,et al.  The involvement of HLA-E and -F in pregnancy. , 2006, Journal of reproductive immunology.

[15]  E. Chiang,et al.  A Nonclassical MHC Class I Molecule Restricts CTL-Mediated Rejection of a Syngeneic Melanoma Tumor1 , 2004, The Journal of Immunology.

[16]  S. Ferrone,et al.  HLA class I defects in malignant lesions: what have we learned? , 2003, The Keio journal of medicine.

[17]  P. Parham,et al.  Stress management: MHC class I and class I-like molecules as reporters of cellular stress. , 2003, Immunity.

[18]  E. Messing,et al.  Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2‐expressing tumors , 2002, The Prostate.

[19]  M. Weller,et al.  A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape1 , 2002, The Journal of Immunology.

[20]  E. Chiang,et al.  The Nonclassical Major Histocompatibility Complex Molecule Qa-2 Protects Tumor Cells from NK Cell- and Lymphokine-Activated Killer Cell-Mediated Cytolysis1 , 2002, The Journal of Immunology.

[21]  S. Ugurel,et al.  Soluble human leukocyte antigen–G serum level is elevated in melanoma patients and is further increased by interferon‐α immunotherapy , 2001 .

[22]  P. Srivastava,et al.  Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70 , 2001, European journal of immunology.

[23]  J. Bell,et al.  Functional characterization of HLA‐F and binding of HLA‐F tetramers to ILT2 and ILT4 receptors , 2000, European journal of immunology.

[24]  J. Robert,et al.  Ontogeny of CTX expression in xenopus. , 1998, Developmental and comparative immunology.

[25]  J. Dausset,et al.  HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Hiroshi Sato,et al.  Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .

[27]  J. Robert,et al.  Antibody cross-linking of the thymocyte-specific cell surface molecule CTX causes abnormal mitosis and multinucleation of tumor cells. , 1997, Experimental cell research.

[28]  M. Flajnik,et al.  A novel type of class I gene organization in vertebrates: a large family of non‐MHC‐linked class I genes is expressed at the RNA level in the amphibian Xenopus. , 1993, The EMBO journal.

[29]  P. Stern,et al.  Loss of MHC class‐I expression in cervical carcinomas , 1990, International journal of cancer.

[30]  Hristina Nedelkovska Nonclassical MHC Class Ib Molecules: Critical Players in Tumor Immune Surveillance and Potential Immunotherapy Targets , 2012 .

[31]  M. Taniguchi,et al.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. , 1997, Science.

[32]  J. Robert,et al.  Lymphoid Tumors of Xenopus laevis with Different Capacities for Growth in Larvae and Adults , 1994, Developmental immunology.

[33]  J. Robert,et al.  Reprints Available Directly from the Publisher Photocopying Permitted by License Only in Vitro Growth of Thymic Tumor Cell Lines from Xenopus , 2022 .